Wiener klinische Wochenschrift · 2020 · 26 citations · 64 references
PharmacyInfectious DiseasesRespiratory TherapyAntimicrobial StewardshipInfectious Disease PharmacotherapyRespiratory PharmacotherapyGuideline ImplementationPandemic PreparednessPandemic ResponsePulmonary InfectionsRespiratory DiseaseRespiratory InfectionsCommunity-acquired Pneumonia TreatmentLung DiseasesPneumonia Empiric TherapyRespiratory Infection TreatmentSars-cov-2 InfectionSars-cov-2 PneumoniaSevere Pneumonia Management
The coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide. In Austria, a crisis within the healthcare system has so far been prevented. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful. The treatment of patients with chronic lung diseases has to be adapted during the pandemic but must still be guaranteed.
64
Xiaobo Yang, Yu Yuan, Jiqian Xu et al. · The Lancet Respiratory Medicine · 2020 · 10.7K citations · Full text
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta, Daniel F. McAuley, Michael Brown et al. · The Lancet · 2020 · 10.2K citations · Full text